96,1 %To detect SCD carrier, SickleScan® had a sensitivity of 96.10% (95% CI: 94.75–97.45).
Malisickle cell disease carrierobservé 2021HAL · Unilimdocument de 103 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 197 evidences · page 36 / 48
96,1 %To detect SCD carrier, SickleScan® had a sensitivity of 96.10% (95% CI: 94.75–97.45).
Malisickle cell disease carrierobservé 2021HAL · Unilimdocument de 103 observations
3 259 specimensA total of 3,259 sandflies were collected in the ZCL foci of Bandiagara area, Mali.
Malizoonotic cutaneous leishmaniasispublié 2012PloS oneeurope_pmcdocument de 3 observations
104 casesThe age group [0–11] months accounted for 104 severe malaria cases out of a total of 2,310 severe cases, representing a severity proportion of 0.045.
MalipaludismeHAL · Unilimdocument de 80 observations
4,2 %Clinical malaria prevalence was 4.2% in 2012 among children in the health district of Koutiala, Mali.
Malipaludismeobservé 2012publié 2020International journal of environmental research and public healtheurope_pmcdocument de 7 observationsDOI 10.3390/ijerph17186639
563,07 pg/mlLe niveau moyen de sRAGE était de 563,07 pg/ml chez les Fulani.
Malipaludismeobservé 2017HAL · Unilimdocument de 31 observations
3 monthsThe duration of the rainy season is consistent with the duration of the high transmission period, varying from 3 months (north) to 5 months (south) according to the analysis of rainfall and malaria data.
MalipaludismeHAL · Unilimdocument de 95 observations
21,79 %Among 3648 newborns diagnosed by HPLC in Mali from April 2021 to August 2021, 21.79% were sickle cell disease carriers.
Malidrépanocytoseobservé April 2021 to August 2021HAL · Unilimdocument de 103 observations
252 per_1000Dans le bras intervention, les agents de santé communautaires ont atteint 1 539 patients et 388 tests antigéniques rapides pour la COVID-19 ont été réalisés, soit 252 tests antigéniques rapides pour 1 000 patients.
MaliCOVID-19HAL · Unilimdocument de 36 observations
21 %A significant proportion of participants believed that COVID-19 was caused by witchcraft (21%).
MaliCOVID-19HAL · Unilimdocument de 88 observations
14 %In Mali, glucose-6-phosphate dehydrogenase (G6PD (A−)) deficiency is found at an overall frequency of 14%.
Maliglucose-6-phosphate dehydrogenase deficiencypublié 2011American Journal of HematologyOpenAlexdocument de 9 observationsDOI 10.1002/ajh.22093
244 000 000 casesIn 2021, there were an estimated 244 million cases of malaria worldwide.
Malipaludismeobservé 2021HAL · Unilimdocument de 111 observations
258 casesOf the 1,389 tested by qPCR RDTs, 258 (18.6%) were positive for Plasmodium spp.
Malipaludismepublié 2023Performance of Rapid Diagnostic Tests for Malaria Diagnosis in Malieurope_pmcdocument de 3 observationsDOI 10.20944/preprints202311.1579.v1
3 casesThree cases of cryptosporidiosis and one case of isosporosis were observed in the leprosy group versus none in the control group.
MaliCryptosporidiosis · isosporosis · leprosyobservé March 1999 to February 2000publié 2002Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument de 7 observations
21,1 %Plasmodium vivax prevalence reached 21.1% in the north of Mali.
Malipaludismepublié 2024International journal of environmental research and public healtheurope_pmcdocument de 5 observations
Higher antibody levels at the time of hospital admission were associated with shorter treatment durations for COVID-19.
MaliCOVID-19HAL · Unilimdocument de 67 observations
94,5 %The highest intermittent preventive treatment in pregnancy (IPTp) coverage rate (94.5%) was observed in the health district of Kangaba (Koulikoro region in the south) in the year 2021–2022.
Malipaludismeobservé 2021–2022HAL · Unilimdocument de 111 observations
18,35 nMQuinine was significantly more potent against Plasmodium malariae than Plasmodium falciparum in Mali, with IC50 values of 18.35 nM versus 26.84 nM.
Malipaludismepublié 2025Microbiology spectrumeurope_pmcdocument de 5 observations
2,08 R0The estimated basic reproduction number (R0) of COVID-19 was 2.08.
MaliCOVID-19HAL · Unilimdocument de 88 observations
31,9 %Among 266 COVID-19 samples, 85 (31.9%) recognized the receptor-binding motif (RBM) antigen.
MaliCOVID-19HAL · Unilimdocument de 67 observations
2 %The prevalence of HbSS in Mali is around 2%.
MalidrépanocytoseHAL · Unilimdocument de 103 observations
98,9 %The adequate clinical and parasite response rate corrected by polymerase chain reaction (ACPRc) among non-AL treatment arms at Mali study sites was 98.9%.
Malipaludismepublié 2021Malaria journaleurope_pmcdocument de 2 observationsDOI 10.1186/s12936-021-03890-0
74 %In Kilifi County, Kenya, 74% of children in the case group had the G6PD normal genotype.
Malidéficit en G6PDpublié 2015The Lancet. Haematologyeurope_pmcdocument de 11 observationsDOI 10.1016/s2352-3026(15)00152-0
912 childrenOverall 912 children aged between six to 59 months with uncomplicated P. falciparum malaria were recruited in the trial in Mali.
Malipaludismepublié 2015Malaria journaleurope_pmcdocument de 7 observations
8 %HIV-attributed mortality among infants and children was 8% in Mali (13 [8%] of 168).
MaliVIH/sidaobservé Dec 3, 2016 to Dec 31, 2024publié 2026The lancet. HIVPubMeddocument de 23 observations
11,29 %Au Mali, la proportion de faible poids de naissance est passée de 11,29 % à 7,6 % entre 2020 et 2023.
Malifaible poids de naissanceobservé 2020 à 2023HAL · Unilimdocument de 302 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.